metricas
covid
Buscar en
Medicina de Familia. SEMERGEN
Toda la web
Inicio Medicina de Familia. SEMERGEN Epidemiological evolution and economic impact of the COVID-19 pandemic in the Eu...
Journal Information
Vol. 50. Issue 6.
(September 2024)
Share
Share
Download PDF
More article options
Visits
597
Vol. 50. Issue 6.
(September 2024)
Original
Epidemiological evolution and economic impact of the COVID-19 pandemic in the European Union and worldwide and effects of control strategies on them: An ecological study
Evolución epidemiológica e impacto económico de la pandemia de COVID-19 en la Unión Europea y a nivel mundial y efectos de las estrategias de control: un estudio ecológico
Visits
597
J.A. Caylàa,
Corresponding author
joan.cayla@uitb.cat

Corresponding author.
, J.M. Bellmuntb,c,d, J.M. Jansàe, A. Marcoa,f,g, J.P. Milleta,e,g
a Tuberculosis Research Unit Foundation of Barcelona, Provença 286°-2-1ª, 08008 Barcelona, Spain
b ABS Barceloneta, Pg. Marítim de la Barceloneta, 25, 08003 Barcelona, Spain
c Pompeu Fabra University, Dr. Aiguader, 88, 08003 Barcelona, Spain
d Hospital del Mar Institute for Medical Research (IMIM), Dr. Aiguader, 88, 08003 Barcelona, Spain
e Epidemiology Service, Public Health Agency of Barcelona, Pl. Lesseps, 1, 08023 Barcelona, Spain
f Infectious Diseases, Prison Health Program, Catalan Health Institute, Gran Via de les Corts Catalanes, 587, 08007 Barcelona, Spain
g CIBER of Epidemiology and Public Health (CIBERESP), Carlos III Health Institute, 28029 Madrid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (5)
Show moreShow less
Tables (1)
Table 1. Evolution of percentage of the annual growth of gross domestic product in relation to previous year in the European Union, worldwide, and in zero-COVID countries (2019–2022).
Abstract
Objective

To evaluate the epidemiological evolution and economic impact of COVID-19 pandemic in the European Union (EU) and worldwide, and the effects of control strategies on them.

Material and methods

We collected incidence, mortality, and gross domestic product (GDP) data between the first quarter of 2020 and of 2023. Then, we reviewed the effectiveness of the mitigation and zero-COVID control strategies. The statistical analysis was done calculating the incidence rate ratio (IRR) of two rates and its 95% confidence interval (CI).

Results

In the EU, COVID-19 presented six epidemic waves. The sixth one at the beginning of 2022 was the biggest. Globally, the biggest wave occurred at the beginning of 2023. Highest mortality rates were observed in the EU during 2020–2021 and globally at the beginning of 2021. In mitigation countries, mortality was much higher than in zero-COVID countries (IRR=6.82 [95% CI: 6.14–7.60]; p<0.001). A GDP reduction was observed worldwide, except in Asia. None of the eight zero-COVID countries presented a GDP growth percentage lower than the EU percentage in 2020, and 3/8 in 2022 (p=0.054). COVID-19 pandemic caused epidemic waves with high mortality rates and a negative impact on GDP.

Conclusion

The zero-COVID strategy was more effective in avoiding mortality and potentially had a lower impact on GDP in the first pandemic year.

Keywords:
COVID-19
SARS-CoV-2
Mitigation strategy
Zero-COVID strategy
Control
Gross domestic product
Evaluation
Resumen
Objetivo

Evaluar la evolución epidemiológica y el impacto económico de la pandemia de COVID-19 en la Unión Europea (UE) y a nivel mundial, así como los efectos de las estrategias de control.

Material y métodos

Recopilamos datos de incidencia, mortalidad y producto interior bruto (PIB) entre 2020 y el primer trimestre de 2023. Luego, revisamos la efectividad de las estrategias de mitigación y de COVID-cero. El análisis estadístico se realizó calculando la razón de tasas de incidencia (RTI) de dos tasas y sus intervalos de confianza (IC) del 95%.

Resultados

En la UE, la COVID-19 presentó seis oleadas epidémicas. La sexta, a principios de 2022, fue la más grande. A nivel mundial, la ola más grande se produjo a principios de 2023. Las tasas de mortalidad más altas se observaron en la UE durante 2020-2021, y a nivel mundial, a principios de 2021. En los países de mitigación, la mortalidad fue mucho mayor que en los países COVID-cero (RTI=6,82 [IC95%: 6,14-7,60]; p<0,001). Se observó una reducción del PIB en todo el mundo, excepto en Asia. Ninguno de los ocho países COVID-cero presentó un porcentaje de crecimiento del PIB inferior al de la UE en 2020, y 3/8 en 2022 (p=0,054). La pandemia de COVID-19 provocó olas epidémicas con altas tasas de mortalidad y un impacto negativo en el PIB.

Conclusión

La estrategia COVID-cero fue más efectiva para evitar la mortalidad, y potencialmente tuvo un menor impacto en el PIB en el primer año de la pandemia.

Palabras clave:
COVID-19
SARS-CoV-2
Mitigación
COVID-cero
Control
Producto interior bruto
Evaluación

Article

These are the options to access the full texts of the publication Medicina de Familia. SEMERGEN
Member
Si es usted socio de SEMERGEN:
Diríjase al área privada de socios de la web de la SEMERGEN, (https://www.semergen.es/index.php?seccion=biblioteca&subSeccion=revistaSEMERGEN ) y autentifíquese.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina de Familia. SEMERGEN

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos